The role of histone acetyltransferases in normal and malignant hematopoiesis

Xiao Jian Sun, Na Man, Yurong Tan, Stephen D Nimer, Lan Wang

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Histone, and non-histone, protein acetylation plays an important role in a variety of cellular events, including the normal and abnormal development of blood cells, by changing the epigenetic status of chromatin and regulating non-histone protein function. Histone acetyltransferases (HATs), which are the enzymes responsible for histone and non-histone protein acetylation, contain p300/CBP, MYST, and GNAT family members. HATs are not only protein modifiers and epigenetic factors but also critical regulators of cell development and carcinogenesis. Here, we will review the function of HATs such as p300/CBP, Tip60, MOZ/MORF, and GCN5/PCAF in normal hematopoiesis and the pathogenesis of hematological malignancies. The inhibitors that have been developed to target HATs will also be reviewed here. Understanding the roles of HATs in normal/malignant hematopoiesis will provide the potential therapeutic targets for the hematological malignancies.

Original languageEnglish (US)
Article number108
JournalFrontiers in Oncology
Volume5
Issue numberMAY
DOIs
StatePublished - 2015

Fingerprint

Histone Acetyltransferases
Hematopoiesis
Hematologic Neoplasms
Acetylation
Epigenomics
Histones
Proteins
Chromatin
Blood Cells
Carcinogenesis
Enzymes

Keywords

  • Hematological malignancies
  • Hematopoiesis
  • Hematopoietic stem cells
  • Histone acetyltransferases
  • Transcriptional regulation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The role of histone acetyltransferases in normal and malignant hematopoiesis. / Sun, Xiao Jian; Man, Na; Tan, Yurong; Nimer, Stephen D; Wang, Lan.

In: Frontiers in Oncology, Vol. 5, No. MAY, 108, 2015.

Research output: Contribution to journalArticle

Sun, Xiao Jian ; Man, Na ; Tan, Yurong ; Nimer, Stephen D ; Wang, Lan. / The role of histone acetyltransferases in normal and malignant hematopoiesis. In: Frontiers in Oncology. 2015 ; Vol. 5, No. MAY.
@article{1a93420134074ba6bc0fbb040955ba65,
title = "The role of histone acetyltransferases in normal and malignant hematopoiesis",
abstract = "Histone, and non-histone, protein acetylation plays an important role in a variety of cellular events, including the normal and abnormal development of blood cells, by changing the epigenetic status of chromatin and regulating non-histone protein function. Histone acetyltransferases (HATs), which are the enzymes responsible for histone and non-histone protein acetylation, contain p300/CBP, MYST, and GNAT family members. HATs are not only protein modifiers and epigenetic factors but also critical regulators of cell development and carcinogenesis. Here, we will review the function of HATs such as p300/CBP, Tip60, MOZ/MORF, and GCN5/PCAF in normal hematopoiesis and the pathogenesis of hematological malignancies. The inhibitors that have been developed to target HATs will also be reviewed here. Understanding the roles of HATs in normal/malignant hematopoiesis will provide the potential therapeutic targets for the hematological malignancies.",
keywords = "Hematological malignancies, Hematopoiesis, Hematopoietic stem cells, Histone acetyltransferases, Transcriptional regulation",
author = "Sun, {Xiao Jian} and Na Man and Yurong Tan and Nimer, {Stephen D} and Lan Wang",
year = "2015",
doi = "10.3389/fonc.2015.00108",
language = "English (US)",
volume = "5",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media S. A.",
number = "MAY",

}

TY - JOUR

T1 - The role of histone acetyltransferases in normal and malignant hematopoiesis

AU - Sun, Xiao Jian

AU - Man, Na

AU - Tan, Yurong

AU - Nimer, Stephen D

AU - Wang, Lan

PY - 2015

Y1 - 2015

N2 - Histone, and non-histone, protein acetylation plays an important role in a variety of cellular events, including the normal and abnormal development of blood cells, by changing the epigenetic status of chromatin and regulating non-histone protein function. Histone acetyltransferases (HATs), which are the enzymes responsible for histone and non-histone protein acetylation, contain p300/CBP, MYST, and GNAT family members. HATs are not only protein modifiers and epigenetic factors but also critical regulators of cell development and carcinogenesis. Here, we will review the function of HATs such as p300/CBP, Tip60, MOZ/MORF, and GCN5/PCAF in normal hematopoiesis and the pathogenesis of hematological malignancies. The inhibitors that have been developed to target HATs will also be reviewed here. Understanding the roles of HATs in normal/malignant hematopoiesis will provide the potential therapeutic targets for the hematological malignancies.

AB - Histone, and non-histone, protein acetylation plays an important role in a variety of cellular events, including the normal and abnormal development of blood cells, by changing the epigenetic status of chromatin and regulating non-histone protein function. Histone acetyltransferases (HATs), which are the enzymes responsible for histone and non-histone protein acetylation, contain p300/CBP, MYST, and GNAT family members. HATs are not only protein modifiers and epigenetic factors but also critical regulators of cell development and carcinogenesis. Here, we will review the function of HATs such as p300/CBP, Tip60, MOZ/MORF, and GCN5/PCAF in normal hematopoiesis and the pathogenesis of hematological malignancies. The inhibitors that have been developed to target HATs will also be reviewed here. Understanding the roles of HATs in normal/malignant hematopoiesis will provide the potential therapeutic targets for the hematological malignancies.

KW - Hematological malignancies

KW - Hematopoiesis

KW - Hematopoietic stem cells

KW - Histone acetyltransferases

KW - Transcriptional regulation

UR - http://www.scopus.com/inward/record.url?scp=84934282991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934282991&partnerID=8YFLogxK

U2 - 10.3389/fonc.2015.00108

DO - 10.3389/fonc.2015.00108

M3 - Article

AN - SCOPUS:84934282991

VL - 5

JO - Frontiers in Oncology

JF - Frontiers in Oncology

SN - 2234-943X

IS - MAY

M1 - 108

ER -